ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Health Technology

Sysmex Corp.

  • 6,600.00 JPY
  • +13.00
  • +0.20%
  • Japan
    Nov 15, 2018
  • Ticker
    TKS(6869)
  • Prev. close
    6,587
  • Market cap (JPY)
    1,377.16B
  • Market cap (USD)
    12,091.53M
  • Shares
    209.07M

Business Summary

Sysmex Corp. engages in the development, manufacture, import, export, and sale of clinical laboratory instruments, reagents, and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, EMEA, China, and Asia Pacific. The company was founded on February 20, 1968 and is headquartered in Kobe, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue281,935M2,543.79M
Gross Profit158,949M1,434.13M
Operating income59,947M540.87M
Income before tax58,117M524.36M
Net income39,221M353.87M
EBITDA74,590M672.99M
Diluted EPS187.841.69
Dividends Per Share660.59
Total Assets321,979M3,027.54M
Total liabilities80,531M757.22M
Total equity240,750M2,263.75M
Operating cash flow52,240M471.34M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 184,538M 221,376M 252,622M 249,899M 281,935M
Gross Profit 112,728M 122,383M 150,690M 141,777M 158,949M
Operating income 32,870M 44,411M 60,710M 50,822M 59,947M
Income before tax 33,451M 45,727M 58,274M 49,623M 58,117M
Net income 20,573M 26,638M 39,278M 40,635M 39,221M
EBITDA 46,118M 57,364M 72,820M 63,203M 74,590M
Diluted EPS 99.16 128.02 188.30 194.74 187.84
Dividends Per Share 27 38 52 58 66
Total Assets 210,758M 247,983M 263,917M 279,817M 321,979M
Total liabilities 64,508M 78,433M 82,864M 71,248M 80,531M
Total equity 146,250M 169,550M 182,801M 209,407M 240,750M
Operating cash flow 36,563M 38,640M 41,794M 32,832M 52,240M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 1,842.22M 2,015.13M 2,103.70M 2,307.73M 2,543.79M
Gross Profit 1,125.34M 1,114.02M 1,254.86M 1,309.26M 1,434.13M
Operating income 328.13M 404.26M 505.56M 469.32M 540.87M
Income before tax 333.93M 416.24M 485.27M 458.25M 524.36M
Net income 205.37M 242.47M 327.08M 375.25M 353.87M
EBITDA 460.39M 522.17M 606.40M 583.65M 672.99M
Diluted EPS 0.98 1.16 1.56 1.79 1.69
Dividends Per Share 0.26 0.34 0.43 0.53 0.59
Total Assets 2,046.49M 2,067.81M 2,348.12M 2,511.14M 3,027.54M
Total liabilities 626.38M 654.01M 737.25M 639.39M 757.22M
Total equity 1,420.10M 1,413.80M 1,626.41M 1,879.26M 2,263.75M
Operating cash flow 365.00M 351.73M 348.03M 303.19M 471.34M

Valuation Measures

Mar 2018
PER51.19
ROA13.03%
ROE17.42%
Operating margin21.26%
Profit margin13.91%

Key executives

  • Chairman & President: Hisashi Ietsugu
  • Manager-Finance: Keishi Matsumoto
  • Director, Head-Technology Development & Strategy: Kaoru Asano
  • Executive Officer: Yukio Hamaguchi
  • Executive Officer: John Kershaw

Shareholders

  • Kobe Yamabuki Foundation (5.7%)
  • Nakatani Foundation (5.6%)
  • Nakatani Kosan YK (5.0%)
  • Capital Research & Management Co. (World Investors) (3.2%)
  • IETSUGU KAZUKO (2.9%)
  • WADA TAEKO (2.9%)
  • ITANI KENJI (2.3%)
  • Estate of Tadashi Nakatani (2.2%)
  • The Vanguard Group, Inc. (2.2%)
  • Nomura Asset Management Co., Ltd. (1.9%)

Contact Details

  • Website:http://www.sysmex.co.jp
  • Address: 1-5-1 Wakinohama-Kaigandori, Chuo-Ku, Kobe, 651-0073, Japan
  • Phone: +81.78.265.0500

Related Companies

  • Sysmex Medical Electronics (Shanghai) Co., Ltd.
  • Sysmex Wuxi Co. Ltd.
  • Sysmex Inostics, Inc.
  • Sysmex Turkey Diagnostik Sistemleri Ltd. STI
  • Sysmex (Malaysia) Sdn.Bhd.
  • Sysmex Vietnam Co. Ltd.
  • Sysmex Taiwan Co. Ltd.
  • Sysmex Suisse AG
  • Sysmex Slovakia sro
  • Sysmex Shanghai Ltd.
  • Sysmex RUS LLC
  • Sysmex Polska Sp zoo
  • Sysmex Philippines, Inc.
  • Sysmex Hungaria Kft.
  • Sysmex Hong Kong Ltd.
  • Sysmex Espana SL
  • Sysmex do Brasil Industria e Comercio Ltda.
  • Sysmex CZ sro
  • Sysmex Canada, Inc.
  • Sysmex Austria GmbH
  • Sysmex Middle East FZ LLC
  • Sysmex South Africa (Pty) Ltd.
  • Sysmex Inostics GmbH
  • Sysmex Korea Co., Ltd.
  • Katakura Industries Co. Ltd. /Biological Research Center/
  • Sysmex RA Co. Ltd.
  • Sysmex Europe GmbH
  • Sysmex Deutschland GmbH
  • Sysmex TMC Co., Ltd.
  • Sysmex International Reagents Co., Ltd.

Competitors

  • bioMerieux SA
  • Haemonetics Corporation
  • Bio-Techne Corporation
  • Biocept, Inc.
  • Epigenomics AG
  • Guardant Health, Inc.
Last Updated on 15 Nov, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media